Zdrowie i gospodarka · 04/02/2011
FDA Amends Animal Drug Regulations for Masitinib Approval
The US Food and Drug Administration (FDA) is updating its animal drug regulations to reflect conditional approval for a new animal drug, masitinib mesylate tablets, intended for use in dogs, following a request from AB Science.
Source: Federal Register — Health and Human ServicesOpen original release →